LivaNova PLC

NASDAQ:LIVN   3:59:54 PM EDT
87.83
+1.53 (+1.77%)
4:51:04 PM EDT: $86.90 -0.93 (-1.06%)
Products

LivaNova Receives FDA Approval For Clinical Study To Evaluate The Aura6000 System

Published: 06/15/2021 13:32 GMT
LivaNova PLC (LIVN) - Livanova Receives FDA Approval for Clinical Study to Evaluate the Aura6000 System to Treat Obstructive Sleep Apnea.
Livanova Plc - Co to Launch Osprey Investigational Device Exemption Clinical Study in U.S.